<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T01:33:04Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10230/69128" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10230/69128</identifier><datestamp>2025-12-18T01:13:43Z</datestamp><setSpec>com_2072_6</setSpec><setSpec>col_2072_452952</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>The case for eliminating excessive worry as a requirement for generalized anxiety disorder: a cross-national investigation</dc:title>
   <dc:creator>Ruscio, Ayelet Meron</dc:creator>
   <dc:creator>Alonso Caballero, Jordi</dc:creator>
   <dc:creator>World Mental Health Survey collaborators</dc:creator>
   <dc:subject>Classification</dc:subject>
   <dc:subject>Diagnosis</dc:subject>
   <dc:subject>Epidemiology</dc:subject>
   <dc:subject>Generalized anxiety disorder</dc:subject>
   <dc:subject>Global mental health</dc:subject>
   <dc:subject>Worry</dc:subject>
   <dc:description>Background: Around the world, people living in objectively difficult circumstances who experience symptoms of generalized anxiety disorder (GAD) do not qualify for a diagnosis because their worry is not &amp;apos;excessive&amp;apos; relative to the context. We carried out the first large-scale, cross-national study to explore the implications of removing this excessiveness requirement. Methods: Data come from the World Health Organization World Mental Health Survey Initiative. A total of 133 614 adults from 12 surveys in Low- or Middle-Income Countries (LMICs) and 16 surveys in High-Income Countries (HICs) were assessed with the Composite International Diagnostic Interview. Non-excessive worriers meeting all other DSM-5 criteria for GAD were compared to respondents meeting all criteria for GAD, and to respondents without GAD, on clinically-relevant correlates. Results: Removing the excessiveness requirement increases the global lifetime prevalence of GAD from 2.6% to 4.0%, with larger increases in LMICs than HICs. Non-excessive and excessive GAD cases worry about many of the same things, although non-excessive cases worry more about health/welfare of loved ones, and less about personal or non-specific concerns, than excessive cases. Non-excessive cases closely resemble excessive cases in socio-demographic characteristics, family history of GAD, and risk of temporally secondary comorbidity and suicidality. Although non-excessive cases are less severe on average, they report impairment comparable to excessive cases and often seek treatment for GAD symptoms. Conclusions: Individuals with non-excessive worry who meet all other DSM-5 criteria for GAD are clinically significant cases. Eliminating the excessiveness requirement would lead to a more defensible GAD diagnosis.</dc:description>
   <dc:date>2025-01-15T07:24:08Z</dc:date>
   <dc:date>2025-01-15T07:24:08Z</dc:date>
   <dc:date>2024</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Ruscio AM, Rassaby M, Stein MB, Stein DJ, Aguilar-Gaxiola S, Al-Hamzawi A, et al. The case for eliminating excessive worry as a requirement for generalized anxiety disorder: a cross-national investigation. Psychol Med. 2024 Oct 4;54(12):1-12. DOI: 10.1017/S003329172400182X</dc:identifier>
   <dc:identifier>0033-2917</dc:identifier>
   <dc:identifier>http://hdl.handle.net/10230/69128</dc:identifier>
   <dc:identifier>http://dx.doi.org/10.1017/S003329172400182X</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Psychol Med. 2024 Oct 4;54(12):1-12</dc:relation>
   <dc:rights>Copyright © The Author(s), 2024. Published by Cambridge University Press. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Cambridge University Press</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>